Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

RVPH stock hub

Reviva Pharmaceuticals Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RVPHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

RVPH

In the news

Latest news · RVPH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-420

P25 -105.6P50 -46.5P75 -3.1

ROIC-244.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RVPH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001742927
Company name	Reviva Pharmaceuticals Holdings, Inc.
Country	United States
Country code	US
Cusip	76152G209
Employees	14
Employees Change	-1%
Employees Change Percent	-6.67
Enterprise value	$-3.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US76152G2093
Last refreshed	2026-05-10
Market cap	$11M
Market cap category	Nano-Cap
Price	$0.86
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	RVPH
Website	https://www.revivapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-181.16%
P/B ratio	0.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-19.9M
Net Income Growth Quarters	7%
Net Income Growth Years	2%
Profit Per Employee	$-1.4M
ROA	-80.35
Roa5y	-79.19
ROCE	-233.6
ROE	-420
Roe5y	-419
ROIC	-244.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-94.56%
Cagr3y	-82.89%
Cagr5y	-62.06%
EPS Growth Quarters	9
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$15.9M
Cash	$14.4M
Current Assets	$15.1M
Current Liabilities	$7.3M
Debt	$406,875
Debt Equity	$0.05
Equity	$8.6M
Interest Coverage	-1,507.2
Liabilities	$7.3M
Long Term Assets	$819,721
Long Term Liabilities	$0
Net Cash	$14M
Net Cash By Market Cap	$128
Net Cash Growth	7.79%
Net Debt Equity	$-1.62
Tangible Book Value	$8.6M
Tangible Book Value Per Share	$1.47
WACC	8.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.08
Net Working Capital	$-6.2M
Quick ratio	1.98
Working Capital	$7.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-114.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-94.54%
200-day SMA	7.15
3Y total return	-99.5%
50-day SMA	1.52
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.21%
All Time High	302
All Time High Change	-99.72%
All Time High Date	2020-12-07
All Time Low	0.59
All Time Low Change	45.08%
All Time Low Date	2026-03-30
ATR	0.11
Beta	0.75
Beta1y	1.02
Beta2y	1.65
Ch YTD	-84.66
High	0.88
High52	23.2
High52 Date	2025-05-27
High52ch	-96.31%
Low	0.83
Low52	0.59
Low52 Date	2026-03-30
Low52ch	45.09%
Ma50ch	-43.76%
Premarket Change Percent	0.3
Premarket Price	$0.87
Premarket Volume	2,450
Price vs 200-day SMA	-88.03%
RSI	34.57
RSI Monthly	33.13
RSI Weekly	29
Sharpe ratio	-0.97x
Sortino ratio	-1.18
Total Return	-114.96%
Tr YTD	-84.66
Tr1m	9.32%
Tr1w	-2.72%
Tr3m	-85.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	4
Analyst Price Target Top	$55.25
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.38
Operating Income	$-20.2M
Price target	$55.17
Price Target Change	$6,345
Price Target Change Top	$6,354

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,173,993%
Float Percent	87.23%
Net Borrowing	-51,279
Shares Insiders	1.37%
Shares Institutions	12.79%
Shares Out	12,810,377
Shares Qo Q	63.43%
Shares Yo Y	114.96%
Short Float	12.79%
Short Ratio	1.26
Short Shares	11.16

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	405,577.8x
Bv Per Share	1.47
Ch1m	9.32
Ch1w	-2.72
Ch1y	-94.54
Ch3m	-85.06
Ch3y	-99.5
Ch5y	-99.21
Ch6m	-91.51
Change	-0.74%
Change From Open	-1.61
Close	0.86
Days Gap	0.88
Dollar Volume	283,151.1
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$-20.2M
EPS	$-5.48
F Score	1
Financing CF	25,557,104
Fiscal Year End	December
Founded	2,006
Income Tax	$18,889
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Date	2026-03-09
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	6.64
Ma150ch	-87.1%
Ma20	0.88
Ma20ch	-2.24%
Net CF	962,461
Next Earnings Date	2026-05-22
Open	0.87
Optionable	Yes
Position In Range	52
Post Close	0.86
Postmarket Change Percent	-0.02
Postmarket Price	$0.86
Pre Close	0.86
Price Date	2026-05-08
Ptbv Ratio	1.27
Relative Volume	0.82x
Share Based Comp	2,227,859
Tr6m	-91.51%
Us State	California
Volume	330,784

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does RVPH pay a dividend?

Capital-return profile for this ticker.

Performance

RVPH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RVPH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.8%

Float: +87.2% of shares outstanding

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RVPH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.6

Neutral momentum band

Price vs 200-day MA

-88.0%

50/200-day relationship not available

Beta (5Y)

0.75

Less volatile than the market

Sharpe ratio

-0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RVPH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RVPH stock rating?

Reviva Pharmaceuticals Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RVPH analysis?

The full report lives at /stocks/RVPH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RVPH?

The latest report frames RVPH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RVPH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.